COMPARATIVE STUDY OF CLINICAL OUTCOMES AFTER DAY-3 CLEAVAGE STAGE AND DAY-5 BLASTOCYST STAGE EMBRYO TRANSFER IN IN-VITRO FERTILIZATION AT THE FERTILITY UNIT OF FEDERAL MEDICAL CENTRE, ABUJA.

COMPARATIVE STUDY OF OUTCOME AFTER DAY-3 CLEAVAGE STAGE AND DAY-5 BLASTOCYST STAGE EMBRYO TRANSFER IN IN-VITRO FERTILIZATION AT THE FERTILITY UNIT OF FEDERAL MEDICAL CENTRE, ABUJA.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202206898636627

Enrollment

104

Registered

2022-06-23

Start date

2022-06-24

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female

Interventions

DAY 3 cleavage stage embryo transfer

DAY5 BLASTOCYST STAGE EMBRYO TRANSFER

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Age must be between 18-39 years. 2. Normal baseline hormonal profile (FSH, LH, E2, Prolactin, and AMH). 3. Normal uterine cavity confirmed by hysterosalpingogram or hysteroscopy.

Exclusion criteria

Exclusion criteria: 1. Maternal age above 39years 2. Women who did not fulfill inclusion criteria. 3. Women who had endocrine or metabolic disorder. 4. Women who had a history of chemotherapy or Radiotherapy 5. Women with uterine anomalies, or focal endometrial lesions (fibroid, polyp, adhesion, endometritis etc). 6. Patients with more than 3 unsuccessful IVF attempts 7. Patients with any contraindication for pregnancy 8. Refusal or inability to comply with the requirements of the study protocol for any reason, including scheduled clinic visits and laboratory tests

Design outcomes

Primary

Measure	Time frame
1.Positive pregnancy test conducted two weeks after embryo transfer 2.Pregnancy confirmation via ultrasound revealing intrauterine gestation at 2 weeks after positive pregnancy test (4 weeks following embryo transfer) 3.Ongoing pregnancy by 20 weeks gestation. SECONDARY OUTCOMES1.Fertilization rates 2.Cleavage rates 3.Blastulation rates 4.Multiple pregnancy rates 5.Early pregnancy losses including: ectopic pregnancy and miscarriages occurring before 20 weeks	—

Measure

Time frame

1.Positive pregnancy test conducted two weeks after embryo transfer 2.Pregnancy confirmation via ultrasound revealing intrauterine gestation at 2 weeks after positive pregnancy test (4 weeks following embryo transfer) 3.Ongoing pregnancy by 20 weeks gestation. SECONDARY OUTCOMES1.Fertilization rates 2.Cleavage rates 3.Blastulation rates 4.Multiple pregnancy rates 5.Early pregnancy losses including: ectopic pregnancy and miscarriages occurring before 20 weeks

—

Secondary

Measure	Time frame
2 SECONDARY OUTCOMES 1. Fertilization rates 2. Cleavage rates 3. Blastulation rates 4. Multiple pregnancy rates 5. Early pregnancy losses including: ectopic pregnancy and miscarriages occurring before 20 weeks	—

Countries

Nigeria

Contacts

Public Contactpeter jegede

health research committee secretary

hrec.fmcabj@gmail.com+2348037779155

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026